The influence of bevacizumab on platelet function
Systemic treatment with bevacizumab is associated with increased rates of arterial and venous thromboembolism and haemorrhage. In order to investigate the pathophysiological mechanism involved, platelet adhesive and aggregatory functions were tested with a platelet function analyser (PFA-100®)...
Main Authors: | M Fehr, S Catschegn, J Madon, L Asmis, R Cathomas, Moos von |
---|---|
Format: | Article |
Language: | English |
Published: |
SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
2011-07-01
|
Series: | Swiss Medical Weekly |
Subjects: | |
Online Access: | https://www.smw.ch/index.php/smw/article/view/1321 |
Similar Items
-
Platelet aggregation measured by single-platelet counting and using PFA-100 devices
by: Natalia Dovlatova, et al.
Published: (2018-10-01) -
The comparison of soluble p-selectin, anti-platelet factor 4, and platelet maximum aggregation levels among coronavirus disease 2019 patients
by: Andhika Rachman, et al.
Published: (2023-01-01) -
Gestational Diabetes Melitus and Cord Blood Platelet Function Studied via the PFA-100 System
by: Vasiliki Mougiou, et al.
Published: (2022-07-01) -
Core and shell platelets of a thrombus: A new microfluidic assay to study mechanics and biochemistry
by: Michael E. DeCortin, et al.
Published: (2020-10-01) -
Evaluation of platelet function in horses undergoing colic surgery using the PFA-100 platelet function analyser
by: A. Iwaszko-Simonik, et al.
Published: (2015-09-01)